Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of cryoprotectants in hematopoietic cell infusion-related adverse events.
Ikeda K, Minakawa K, Yamahara K, Yamada-Fujiwara M, Okuyama Y, Fujiwara SI, Yamazaki R, Kanamori H, Iseki T, Nagamura-Inoue T, Kameda K, Nagai K, Fujii N, Ashida T, Hirose A, Takahashi T, Ohto H, Ueda K, Tanosaki R. Ikeda K, et al. Among authors: yamahara k. Transfusion. 2022 Jun;62(6):1280-1288. doi: 10.1111/trf.16877. Epub 2022 Apr 9. Transfusion. 2022. PMID: 35396716
Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia.
Yoshihara S, Ikemoto J, Onomoto H, Sugiyama H, Okuda N, Fukunaga K, Yoshihara K, Kaida K, Ikegame K, Tamaki H, Okada M, Osugi Y, Yamahara K, Higasa S, Fujimori Y. Yoshihara S, et al. Among authors: yamahara k. Transfus Med. 2021 Oct;31(5):365-370. doi: 10.1111/tme.12795. Epub 2021 Jun 6. Transfus Med. 2021. PMID: 34096118
Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial.
Yamahara K, Hamada A, Soma T, Okamoto R, Okada M, Yoshihara S, Yoshihara K, Ikegame K, Tamaki H, Kaida K, Inoue T, Ohsugi Y, Nishikawa H, Hayashi H, Ito YM, Iijima H, Ohnishi S, Hashimoto D, Isoe T, Teshima T, Ogawa H, Sato N, Fujimori Y. Yamahara K, et al. BMJ Open. 2019 Jul 9;9(7):e026403. doi: 10.1136/bmjopen-2018-026403. BMJ Open. 2019. PMID: 31289066 Free PMC article.
Oral administration of conditioned medium obtained from mesenchymal stem cell culture prevents subsequent stricture formation after esophageal submucosal dissection in pigs.
Mizushima T, Ohnishi S, Hosono H, Yamahara K, Tsuda M, Shimizu Y, Kato M, Asaka M, Sakamoto N. Mizushima T, et al. Among authors: yamahara k. Gastrointest Endosc. 2017 Sep;86(3):542-552.e1. doi: 10.1016/j.gie.2017.01.024. Epub 2017 Jan 31. Gastrointest Endosc. 2017. PMID: 28153569 Free article.
Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients.
Taguchi A, Sakai C, Soma T, Kasahara Y, Stern DM, Kajimoto K, Ihara M, Daimon T, Yamahara K, Doi K, Kohara N, Nishimura H, Matsuyama T, Naritomi H, Sakai N, Nagatsuka K. Taguchi A, et al. Among authors: yamahara k. Stem Cells Dev. 2015 Oct 1;24(19):2207-18. doi: 10.1089/scd.2015.0160. Epub 2015 Aug 17. Stem Cells Dev. 2015. PMID: 26176265 Free PMC article. Clinical Trial.
Intravenous Administration of Human Amniotic Mesenchymal Stem Cells in the Subacute Phase of Cerebral Infarction in a Mouse Model Ameliorates Neurological Disturbance by Suppressing Blood Brain Barrier Disruption and Apoptosis via Immunomodulation.
Yoshida Y, Takagi T, Kuramoto Y, Tatebayashi K, Shirakawa M, Yamahara K, Doe N, Yoshimura S. Yoshida Y, et al. Among authors: yamahara k. Cell Transplant. 2021 Jan-Dec;30:9636897211024183. doi: 10.1177/09636897211024183. Cell Transplant. 2021. PMID: 34144647 Free PMC article.
166 results